Project Farma (PF) is a patient-focused global leader in advancing technical operations and providing manufacturing solutions from ideation through commercialization, offering end-to-end services for the entire manufacturing lifecycle. The company serves a diverse range of clients, from pharma to startup and established biotech, including cell and gene, RNA-based, and radioligand therapies, CMO and CDMO, academia, financial institutions, and more.
A core value of Project Farma is giving back, demonstrated through volunteering at hospitals, supporting healthcare-related fundraisers, and partnering with nonprofit organizations, which is an integral part of the company's culture. By doing so, the company not only raises awareness of life-threatening diseases but also brings its team and clients closer to the patients and families impacted by their work.
Project Farma is a Precision for Medicine company, emphasizing its strong commitment to precision in the healthcare and pharmaceutical industries. Founded in 2016, the company operates in the health care, manufacturing, medical devices, and pharmaceutical sectors.
Currently, there is no public information available regarding Project Farma's last investment or the investors involved. The company's headquarters location is not provided. For more information, visit https:\/\/www.precisionformedicine.com\/manufacturing-solutions.
There is no investment information
No recent news or press coverage available for Project Farma (PF).